ArticleJournal of inflammation research2026

First-Line Guselkumab Combined with Exclusive Enteral Nutrition in Biologic-Naïve Young‑Onset Crohn's Disease: A Three-Case Series from China.

Sumei Sha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.